AI NewsWaveOracle Partners With AstraZeneca to Find Clinical Trial Patients Using AI
Key points
- Oracle and AstraZeneca agree on AI clinical trial collaboration
- Using real-world clinical data to help identify eligible patients
- Chosun Biz reports it as a non-binding agreement
Oracle has entered into an agreement with global pharmaceutical company AstraZeneca to improve the efficiency of clinical trials using AI and real-world clinical data (RWD). Datanet and Chosun Biz reported that Oracle announced it on Oct. 21.
According to the outlets, the collaboration involves helping clinicians identify eligible patients for clinical trials, accelerating the generation of clinical evidence, and exploring ways to bring research insights into everyday care. Digital Daily reported that the goal is to reduce the time it takes to recruit patients.
Chosun Biz specifically noted the nature of the agreement. It reported that the two companies signed a non-binding agreement.